NVCR Q1 2024 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q1 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$139M+13.4% YoY

Gross Profit

$105M75.7% margin

Operating Income

-$42M-30.0% margin

Net Income

-$39M-28.0% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

+3.5%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$43M

Stock-Based Comp.

$34M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$762M

Stockholders' Equity

$359M

Cash & Equivalents

$454M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$139M	$122M	+13.4%
Gross Profit	$105M	$93M	+13.2%
Operating Income	-$42M	-$60M	+31.1%
Net Income	-$39M	-$53M	+27.0%

Geographic Segments

UNITED STATES

$91M56%

International Markets

$43M27%

GERMANY

$16M10%

JAPAN

$8M5%

CHINA

$5M3%